Telephone:

(443) 267-6601

©2018 by IES Life Sciences.

IES Life Sciences, Inc.

Eastern Shore Innovation Center

104 Tech Park Drive

Suite 28

Cambridge, MD 21613

  • LinkedIn Social Icon
  • Facebook
  • YouTube

WELCOME TO

IES Life Sciences

The Future of Biotechnology

 

ABOUT US

IES Life Sciences is dedicated to the discovery and development of targeted diagnostics and therapeutics that harness the power of the immune system to improve patient outcomes.

Learn more about our current patented technology

 

TESTIMONIALS

- Investor

- Patient

OUR RESEARCH

 
DNA

TARGETED THERAPEUTICS

The body’s earliest response to infections/diseases is to make cellular proteins called interferons, commonly referred to as "IFNs". IFNs are present in most diseases and viruses and each virus/disease produces a unique set of the 21 different IFNs (the “IFN Signature”). IES has co-developed, with leading FDA scientists, the first and only
comprehensive test to accurately and reliably identify the IFN Signature for a disease. IES’s patented technology (U.S. Patent 9,193995) can detect and diagnose a wide variety of traditionally DIFFICULT to diagnose diseases, at the earliest possible stage, with a simple blood test. In addition, the test can be used as the cornerstone for the development of targeted therapeutics that attack diseases by regulating the immune system.

MULTITUDE OF APPLICATIONS

There are a multitude of opportunities for the development of diagnostics for other autoimmune diseases with significant diagnostic challenges including Lyme, MS and Rheumatoid Arthritis. In addition, because IES can identify contagious diseases immediately following exposure with a simple blood test, the technology has significant national security and military applications. In the event of an outbreak of a disease of unknown origin, the IES test can be deployed to quickly and reliably identify the source of the outbreak, accelerating response times and significantly aiding in containing and combatting the outbreak. Because the test can identify a virus or disease immediately following exposure, the test can be used to screen troops deployed to an area with a contagious outbreak, rapidly identifying infected individuals, providing for early intervention and eliminate the need for prolonged quarantines of the entire deployment.

Taking the pulse of an older patient

CONTACT US

IES Life Sciences, Inc.
Eastern Shore Innovation Center
104 Tech Park Drive
Suite 28
Cambridge, MD 21613

Phone: (443) 267-6601

 

LEARN MORE

Recent news, events and updates

Our website is currently under construction 

Don't miss any updates!

Contact us for more information